Computational modeling of TC0583 as a putative component of the Chlamydia muridarum V-type ATP synthase complex and assessment of its protective capabilities as a vaccine antigen

2009, Chlamydia screening among sexually active young female enrollees of health plans–United States, 2000-2007, MMWR Morb Mortal Wkly Rep, 58, 362 Schachter, 1978 Darville, 2013, Sex Transm Dis, 40, 761, 10.1097/OLQ.0000000000000028 Beem, 1977, Respiratory-tract colonization and a distinctive pneumonia syndrome in infants infected with Chlamydia trachomatis, N Engl J Med, 296, 306, 10.1056/NEJM197702102960604 Brunham, 2005, The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection, J Infect Dis, 192, 1836, 10.1086/497341 Gotz, 2002, Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods?, Scand J Infect Dis, 34, 28, 10.1080/00365540110077001 Nichols, 1966, Studies on trachoma. V. Clinical observations in a field trial of bivalent trachoma vaccine at three dosage levels in Saudi Arabia, Am J Trop Med Hyg, 15, 639, 10.4269/ajtmh.1966.15.639 Dawson, 1967, Experimental inclusion conjunctivitis in man. 3. Keratitis and other complications, Arch Ophthalmol, 78, 341, 10.1001/archopht.1967.00980030343015 Farris, 2011, Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model, Infect Immun, 79, 986, 10.1128/IAI.00881-10 de la Maza, 2002, Vaccines for Chlamydia trachomatis infections, Curr Opin Investig Drugs, 3, 980 Brunham, 2005, Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine, Nat Rev Immunol, 5, 149, 10.1038/nri1551 Morrison, 1989, Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein, J Exp Med, 169, 663, 10.1084/jem.169.3.663 Rockey, 2009, Chlamydia vaccine candidates and tools for chlamydial antigen discovery, Expert Rev Vaccines, 8, 1365, 10.1586/erv.09.98 Molina, 2010, Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays, Vaccine, 28, 3014, 10.1016/j.vaccine.2009.12.020 Cheng, 2014, Assessment of the role in protection and pathogenesis of the Chlamydia muridarum V-type ATP synthase subunit A (AtpA) (TC0582), Microbes Infect, 16, 123, 10.1016/j.micinf.2013.10.012 Mulkidjanian, 2007, Inventing the dynamo machine: the evolution of the F-type and V-type ATPases, Nat Rev Microbiol, 5, 892, 10.1038/nrmicro1767 Stephens, 1998, Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis, Science, 282, 754, 10.1126/science.282.5389.754 Read, 2000, Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39, Nucleic Acids Res, 28, 1397, 10.1093/nar/28.6.1397 Albrecht, 2010, Deep sequencing-based discovery of the Chlamydia trachomatis transcriptome, Nucleic Acids Res, 38, 868, 10.1093/nar/gkp1032 Caldwell, 1981, Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis, Infect Immun, 31, 1161, 10.1128/iai.31.3.1161-1176.1981 Qin, 2008, Construction of a series of vectors for high throughput cloning and expression screening of membrane proteins from Mycobacterium tuberculosis, BMC Biotechnol, 8, 51, 10.1186/1472-6750-8-51 Sun, 2009, Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein, Vaccine, 27, 5020, 10.1016/j.vaccine.2009.05.008 Pal, 2001, Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge, Infect Immun, 69, 6240, 10.1128/IAI.69.10.6240-6247.2001 Zhang, 2008, I-TASSER server for protein 3D structure prediction, BMC Bioinforma, 9, 40, 10.1186/1471-2105-9-40 Zhang, 2009, I-TASSER: fully automated protein structure prediction in CASP8, Proteins, 77, 100, 10.1002/prot.22588 Roy, 2010, a unified platform for automated protein structure and function prediction, Nat Protoc, 5, 725, 10.1038/nprot.2010.5 Zemla, 2003, LGA: a method for finding 3D similarities in protein structures, Nucleic Acids Res, 31, 3370, 10.1093/nar/gkg571 DeLano, 2009, PyMOL molecular viewer: updates and refinements, Abstr Pap Am Chem S, 238 Thompson, 2002 Gouet, 2003, ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins, Nucleic Acids Res, 31, 3320, 10.1093/nar/gkg556 Cheng, 2011, A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors, Vaccine, 29, 6641, 10.1016/j.vaccine.2011.06.105 Pal, 2005, Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria, Infect Immun, 73, 8153, 10.1128/IAI.73.12.8153-8160.2005 Pal, 1994, Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis, Infect Immun, 62, 3354, 10.1128/iai.62.8.3354-3362.1994 Cheng, 2009, Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin, Vaccine, 27, 6239, 10.1016/j.vaccine.2009.07.108 Pal, 2002, Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge, Infect Immun, 70, 4812, 10.1128/IAI.70.9.4812-4817.2002 von Ballmoos, 2008, Unique rotary ATP synthase and its biological diversity, Annu Rev Biophys, 37, 43, 10.1146/annurev.biophys.37.032807.130018 Muench, 2011, Structural divergence of the rotary ATPases, Q Rev Biophys, 44, 311, 10.1017/S0033583510000338 Forgac, 2007, Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology, Nat Rev Mol Cell Biol, 8, 917, 10.1038/nrm2272 Zhang, 2004, Scoring function for automated assessment of protein structure template quality, Proteins, 57, 702, 10.1002/prot.20264 Holm, 2010, Dali server: conservation mapping in 3D, Nucleic Acids Res, 38, W545, 10.1093/nar/gkq366 Iwata, 2004, Crystal structure of a central stalk subunit C and reversible association/dissociation of vacuole-type ATPase, Proc Natl Acad Sci U S A, 101, 59, 10.1073/pnas.0305165101 Omsland, 2014, Chlamydial metabolism revisited: interspecies metabolic variability and developmental stage-specific physiologic activities, FEMS Microbiol Rev, 38, 779, 10.1111/1574-6976.12059 Barta, 2014, Structural and biochemical characterization of Chlamydia trachomatis hypothetical protein CT263 supports that menaquinone synthesis occurs through the futalosine pathway, J Biol Chem, 289, 32214, 10.1074/jbc.M114.594325 Tifrea, 2013, Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis, Infect Immun, 81, 1741, 10.1128/IAI.00734-12 Kari, 2009, Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine, J Immunol, 182, 8063, 10.4049/jimmunol.0804375 Zeng, 2012, Identification of antigen-specific antibody responses associated with upper genital tract pathology in mice infected with Chlamydia muridarum, Infect Immun, 80, 1098, 10.1128/IAI.05894-11 Mabey, 2014, Towards a safe and effective chlamydial vaccine: lessons from the eye, Vaccine, 32, 1572, 10.1016/j.vaccine.2013.10.016 Perry, 1997, Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways, J Immunol, 158, 3344, 10.4049/jimmunol.158.7.3344 Finco, 2011, Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines, Proc Natl Acad Sci U S A, 108, 9969, 10.1073/pnas.1101756108 Yu, 2010, Infect Immun, 78, 2272, 10.1128/IAI.01374-09